Skip to main content

ERC

News

Participate
Products
- Gliovac/ERC1671
Media
- News
- Publications
About
Contact

News Publications

15

May

2016

Approval for open phase II study

ULB Belgium’s ethical commitee has approved the protocol for an open phase II study of standard treatments in combination with Gliovac/ERC1671 vs standard treatments without Gliovac/ERC1671 in the treatment of Glioblastoma multiforme. For further information go to the publications page.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.

Close

Made byKonnu

Cookie information

Top